Key result
Coronary artery bypass grafting in patients with left ventricular dysfunction (EF ≤ 30%) was associated with a hospital mortality rate of 6.3% and a 2-year survival rate of 82%.
Cohort (n=80)
No
CABG in patients with severe left ventricular dysfunction has an acceptably low operative risk and good 2-year survival, though patients with extensive LV dilatation and significant mitral regurgitation have worse outcomes.
Supports CABG consideration in severe LV dysfunction; extends observational data but leaves optimal selection open.
In order to identify the risk factors which could predict outcome after coronary artery bypass grafting in patients with left ventricular dysfunction, 80 consecutive patients with an ejection fraction ≤ 30%, who underwent isolated coronary artery bypass grafting at the authors' centre between January 1994 and May 1996 were evaluated. Preoperatively, mean(s.d.) ejection fraction was 27.1(3.8)%, 56 patients (70%) had angina, and 56 (70%) were in New York Heart Association (NYHA) functional class III or IV. There were five operative deaths, with a hospital mortality rate of 6.3%. Significant risk factors for hospital death were NYHA class IV, preoperative ventricular arrhythmias and left ventricular end-diastolic volume index > 110 ml/m 2 . At mean follow-up of 15(7) (range 6–30) months, there were six late deaths, five of which were from cardiac causes. Actuarial survival rate at 2 years was 82(5)% and freedom from cardiac death 84(5)%. Risk factors for overall mortality from cardiac causes were preoperative grade 2 mitral regurgitation, associated with left ventricular dilatation, and renal dysfunction (creatininaemia ≥ 180 μmol/l). At follow-up, mean ejection fraction was 37.5(8.4)%, and the overall functional status had improved: 12 patients (18%) had angina and eight (12%) were in NYHA class III and IV. Myocardial revascularization in patients with left ventricular dysfunction can be performed with acceptably low operative risk, good survival rate at 2 years, and functional status improvement. Patients with extensive ventricular dilatation, associated with significant mitral regurgitation, have a lower life expectancy and less functional benefits from coronary artery bypass grafting. These patients are better treated by cardiac transplantation.
No takes yet. Share an insight, caveat, or question.
Carlo et al. (1998) conducted a cohort in Left ventricular dysfunction (n=80). Coronary artery bypass grafting was evaluated on Hospital mortality. Coronary artery bypass grafting in patients with left ventricular dysfunction (EF ≤ 30%) was associated with a hospital mortality rate of 6.3% and a 2-year survival rate of 82%.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: